Browse All / Modules / Nephrotic Podocyte Injury Module

Nephrotic Podocyte Injury Module

Module nephrotic_podocyte_injury 1 disorder Pathograph 5
A conserved podocytopathy module representing the convergent glomerular filtration barrier failure that underlies nephrotic syndrome across primary and secondary causes. A podocyte insult — a circulating permeability factor, an immune or toxic mechanism, or an inherited slit-diaphragm/cytoskeleton gene defect (e.g., nephrin, podocin, actin-regulating proteins) — destabilizes the podocyte actin cytoskeleton, triggering foot process effacement and slit diaphragm disruption. Loss of this junctional architecture breaks the size- and charge-selective glomerular filtration barrier, producing massive proteinuria with progressive podocyte detachment, loss, and glomerulosclerosis. The convergent clinical consequence is nephrotic syndrome (nephrotic-range proteinuria, hypoalbuminemia, edema, and hyperlipidemia). Minimal change disease, focal segmental glomerulosclerosis, genetic NPHS1/NPHS2 podocyte-gene disorders, and secondary nephrotic syndromes all converge on this chain; conforming disorder nodes substitute the disorder-specific initiating lesion while preserving the conserved causal sequence.
⚙

Pathophysiology Nodes

5
5 shared nodes are defined in this module.
◉

Cell Types

1
podocyte CL:0000653
⇄

Biological Processes

4
actin cytoskeleton organization GO:0030036 ABNORMAL cell-cell junction organization GO:0045216 DECREASED cell adhesion GO:0007155 DECREASED glomerular filtration GO:0003094 ABNORMAL
i

Notes

This is a mechanism module, not a specific disease. Disorder entries reference individual nodes via conforms_to (e.g., "nephrotic_podocyte_injury#Glomerular Filtration Barrier Breakdown"). The module defines the expected pathophysiology structure; conforming nodes in disorder files should include the corresponding podocyte cell type, biological processes, and causal edges, specialized to their etiologic context. Key disorder-specific substitutions: genetic forms substitute the mutated slit-diaphragm/cytoskeleton gene product (nephrin in NPHS1, podocin in NPHS2); minimal change disease and primary FSGS substitute a circulating permeability factor or immune mechanism as the trigger; secondary forms (diabetic nephropathy, lupus, membranous) substitute their specific glomerular insult while preserving podocyte injury as the central lesion.
↗

Used By Disorder Entries

1
Focal Segmental Glomerulosclerosis via Glomerular Filtration Barrier Dysfunction → Glomerular Filtration Barrier Breakdown
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence-backed metadata.
Pathograph: causal mechanism network for Nephrotic Podocyte Injury Module Interactive directed graph showing how this shared module's pathophysiology nodes connect.
⚙

Pathophysiology

5
Podocyte Injury
trigger
A circulating permeability factor, immune or toxic mechanism, or an inherited mutation in a slit-diaphragm or cytoskeletal protein (nephrin, podocin, or actin-regulating proteins) injures the glomerular podocyte. Across primary, genetic, and secondary nephrotic syndromes the initiating lesion converges on the podocyte and its actin cytoskeleton, the central target whose perturbation begins the pathway to filtration barrier failure.
podocyte CL:0000653
actin cytoskeleton organization GO:0030036 ABNORMAL
Downstream
  • Foot Process Effacement and Slit Diaphragm Disruption
Foot Process Effacement and Slit Diaphragm Disruption
amplifier
Injured podocytes reorganize their actin cytoskeleton, leading to foot process effacement and disruption of the slit diaphragm — the specialized cell-cell junction between adjacent podocyte foot processes. The slit diaphragm backbone protein nephrin and the adaptor podocin normally link the junction to the foot process actin bundles; loss of this junctional adhesion is a stereotyped change seen across all forms of nephrotic syndrome.
podocyte CL:0000653
cell-cell junction organization GO:0045216 DECREASED cell adhesion GO:0007155 DECREASED
Downstream
  • Glomerular Filtration Barrier Breakdown
Glomerular Filtration Barrier Breakdown
central effector
Loss of foot process and slit diaphragm integrity, together with podocyte, glomerular basement membrane, and endothelial dysfunction, breaks down the size- and charge-selective glomerular filtration barrier. The barrier can no longer restrain plasma proteins, so albumin and larger proteins pass into the urinary space. This is the central effector step that converts a podocyte structural lesion into pathological filtration.
podocyte CL:0000653
glomerular filtration GO:0003094 ABNORMAL
Used by disorders
Focal Segmental Glomerulosclerosis as Glomerular Filtration Barrier Dysfunction
Downstream
  • Massive Proteinuria with Podocyte Loss
Massive Proteinuria with Podocyte Loss
effector
Sustained barrier failure produces massive proteinuria. Because podocytes are terminally differentiated and do not normally divide, ongoing injury leads to their detachment from the glomerular basement membrane and progressive podocyte loss. Once podocyte loss exceeds a critical threshold in a glomerulus, glomerulosclerosis develops and the glomerulus is progressively obliterated, establishing chronic, often progressive disease.
podocyte CL:0000653
glomerular filtration GO:0003094 ABNORMAL
Downstream
  • Nephrotic Syndrome
Nephrotic Syndrome
consequence
The convergent clinical consequence of glomerular filtration barrier failure is nephrotic syndrome: nephrotic-range proteinuria with hypoalbuminemia, peripheral edema, and hyperlipidemia. Whatever the initiating podocyte insult — minimal change disease, focal segmental glomerulosclerosis, genetic podocyte-gene disorders, or secondary causes — the disease-defining phenotype is shared, with complications including thrombosis and infection.